Lichen Planus

Researchers investigated prevalence rates and current treatment practices for lichen planus and found a need for further research, according to a study.

Secukinumab did not reach proof of concept in patients with lichen planus, according to results of a phase 2 study.

Acitretin in combination with topical triamcinolone acetonide 0.1% may be a better treatment option than triamcinolone acetonide alone for patients with oral lichen planus, according to a study.

NEW ORLEANS — A first-in-human study found patients with lichen planus treated with the Janus kinase inhibitor baracitinib achieved almost total improvement, according to a presenter at the American Academy of Dermatology Annual Meeting.

Early diagnosis and intervention are critical in managing lichen planus, a benign inflammatory disorder that may affect the skin, mucosae, scalp and nails, according to the authors of a set of consensus recommendations.

Oral lichen planus is more likely to occur in non-Asian countries and among women, according to results of a meta-analysis investigating this disease.